Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Surface Area Determination (BET Method) – V 2.0

Posted on By

Analytical Method Development: SOP for Surface Area Determination (BET Method) – V 2.0

Standard Operating Procedure for BET Surface Area Determination in Pharmaceutical Analysis


Department Analytical Method Development
SOP No. SOP/AMD/180/2025
Supersedes SOP/AMD/180/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the standardized procedure for determining the specific surface area of pharmaceutical powders and porous solids using the BET (Brunauer–Emmett–Teller) method. Surface area data

is critical for understanding dissolution rates, adsorption properties, and compressibility in formulation development.

2. Scope

This SOP applies to the Analytical Method Development (AMD) department and is intended for solid APIs, excipients, and processed materials requiring surface area characterization during R&D, quality control, and stability testing phases.

3. Responsibilities

  • Analytical Scientist: Develops and validates the BET method, selects appropriate degassing and analysis parameters.
  • Instrument Analyst: Prepares samples, operates the surface area analyzer, and records data.
  • QA Officer: Ensures reviewed data complies with regulatory standards.
  • Head – AMD: Authorizes the validated method and ensures integration into product development workflows.
See also  Analytical Method Development: SOP for Tonicity Testing Method Development - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring the BET method is scientifically robust, reproducible, and compliant with ICH and USP requirements.

5. Procedure

5.1 Instrument Calibration

  1. Use a certified reference material (e.g., alumina or silica with known surface area).
  2. Calibrate the instrument for:
    • Dead volume
    • Leak check
    • Flow rate accuracy
  3. Record all calibration data in Annexure-1: BET Calibration Log.

5.2 Sample Preparation

  1. Weigh 0.2–1.0 g of accurately measured dry sample into the analysis tube.
  2. Degas sample under vacuum or flowing nitrogen at suitable temperature (e.g., 100°C–150°C) for 2–6 hours depending on sample sensitivity.
  3. Document degassing conditions in Annexure-2: Sample Prep Log.

5.3 Method Parameters

  1. Adsorbate Gas: Nitrogen (N₂)
  2. Temperature: Liquid nitrogen bath (~77 K)
  3. Relative Pressure (P/P₀): 0.05–0.3 for BET range
  4. BET Equation: Used to calculate monolayer capacity (Vm) and surface area (m²/g)
  5. Number of Data Points: Minimum 5–7 in linear BET region
See also  Analytical Method Development: Method Transfer for Dissolution Studies - V 2.0

5.4 Analysis and Calculation

  1. Initiate adsorption analysis and collect isotherm data (adsorption and desorption branches).
  2. Plot BET graph and ensure linearity in selected P/P₀ range (R² ≥ 0.995).
  3. Calculate:
    • Monolayer capacity (Vm)
    • Specific surface area using molecular cross-sectional area of nitrogen (0.162 nm²)
  4. Log surface area results in Annexure-3: Surface Area Report.

5.5 Method Validation

  1. Validate according to USP <846> and ICH Q2(R2) guidance:
    • Repeatability: Surface area results within ±3% across 3 replicate measurements
    • Specificity: No interference from impurities or moisture
    • Linearity: Ensure BET region fits R² ≥ 0.995
    • Robustness: Assess effect of degassing time and sample mass
  2. Summarize validation in Annexure-4: BET Validation Summary.

5.6 Critical Points and Troubleshooting

  1. Ensure proper degassing to avoid low surface area readings.
  2. Avoid moisture exposure post-degassing.
  3. Ensure liquid nitrogen levels remain stable during analysis.

6. Abbreviations

  • BET: Brunauer–Emmett–Teller
  • Vm: Monolayer Capacity
  • R&D: Research and Development
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. BET Calibration Log – Annexure-1
  2. Sample Prep Log – Annexure-2
  3. Surface Area Report – Annexure-3
  4. BET Validation Summary – Annexure-4

8. References

  • USP <846> – Surface Area Determination
  • ICH Q2(R2) – Validation of Analytical Procedures
  • FDA Guidance for Industry – Nanotechnology

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: BET Calibration Log

Date Standard Used Theoretical SA (m²/g) Observed SA (m²/g) Analyst
18/05/2025 Alumina 93.5 92.8 Rajesh Kumar

Annexure-2: Sample Prep Log

Sample ID Weight (g) Degassing Temp (°C) Time (hrs) Analyst
API-BET-112 0.350 120 4 Sunita Reddy

Annexure-3: Surface Area Report

Sample ID BET Area (m²/g) Vm (cm³/g) P/P₀ Range Analyst
EXC-27 56.2 11.8 0.05–0.30 Sunita Reddy

Annexure-4: BET Validation Summary

Parameter Result Criteria Status
Repeatability RSD = 2.3% ≤ 3% Pass
Linearity (BET Plot) R² = 0.996 ≥ 0.995 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated degassing conditions and included validation annexures Annual SOP Review
See also  Analytical Method Development: SOP for Osmolality Measurement in Sterile Products - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Process Validation Procedure for Gel Manufacturing – V 2.0
Next Post: Elixir Department: SOP for Operation of Filter Press – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version